Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by a team of seasoned investment veterans and operators, LYFE Capital is a prominent healthcare investment platform with a global presence, including offices in the United States and Asia. The firm manages approximately $2 billion in assets under management (AUM) and has raised a total fund size of $2 billion. LYFE Capital is dedicated to investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services. The firm has established a reputation for targeting high-potential businesses across various medical specialties and stages of development, particularly in mature markets. With a portfolio of seven companies, LYFE Capital is well-positioned to leverage its extensive network and expertise to scale its investments into market leaders. The firm’s strategic focus on healthcare allows it to navigate the complexities of the industry effectively, making it a valuable partner for startups looking to innovate and grow.
LYFE Capital specializes in investing in healthcare companies that are integral to the global value chain. The firm’s investment strategy encompasses a wide range of medical specialties and stages of development, including pre-seed, seed, seed-plus, Series A, Series B, and Series C funding rounds. LYFE Capital is particularly interested in high-potential businesses that demonstrate the capability to scale and become market leaders. The firm’s geographic focus spans North America and Asia, allowing it to tap into diverse healthcare markets and trends. LYFE Capital seeks to partner with innovative companies that are addressing critical healthcare challenges and improving patient outcomes. By concentrating on mature markets, the firm aims to identify and support businesses that can leverage existing infrastructure and expertise to drive growth and enhance operational efficiency.
LYFE Capital's portfolio includes several notable companies that exemplify its investment strategy in the healthcare sector. Among these is **ST Pharm**, a South Korean contract development and manufacturing organization (CDMO) specializing in oligonucleotide synthesis, which has established partnerships with major pharmaceutical companies such as GSK, Novartis, Roche, and BMS. Another key investment is **Edge Medical**, a China-based surgical robotic company known for its innovative multi-port and single-port endoscopy systems. **Profound Bio**, located in Seattle, is an antibody-drug conjugate (ADC) platform with assets currently in clinical trials, showcasing LYFE's commitment to cutting-edge medical technologies. Additionally, **Bora Pharmaceuticals** is a global drug development and manufacturing company recognized for its expertise in M&A integration and commercial operations in North America. Other portfolio companies include **Brightech**, a New Jersey-based data service contract research organization (CRO) that optimizes operations through its Asian connections, **Noah Medical**, specializing in endoluminal robotics in California, and **Jeisis Medical**, a South Korean firm known for its energy-based medical aesthetic devices. This diverse portfolio reflects LYFE Capital's strategic focus on essential healthcare innovations.
To pitch LYFE Capital, please email newlp@lyfecapital.com with a detailed overview of your business. They appreciate clear and concise pitches that highlight your value proposition and market opportunity. Warm introductions are beneficial but not mandatory.
LYFE Capital invests across multiple stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. This broad investment range allows them to support companies at various points in their development journey.
Founders interested in pitching LYFE Capital can reach out via email at newlp@lyfecapital.com. It is advisable to provide a clear and concise overview of your business, including your value proposition, market opportunity, and how you plan to scale.
LYFE Capital primarily focuses on the healthcare and biotech sectors. They invest in companies that are critical to the healthcare supply chain and those that offer innovative solutions in medical specialties.
While specific check sizes are not detailed, LYFE Capital targets high-potential businesses across various funding stages, indicating a flexible approach to investment amounts based on the needs of the companies they support.
LYFE Capital has a global investment focus, with particular emphasis on North America and Asia. This geographic diversity allows them to tap into different healthcare markets and trends.
The application process involves reaching out via email at newlp@lyfecapital.com. Founders should prepare a compelling pitch that outlines their business model, market potential, and growth strategy.
LYFE Capital emphasizes scaling high-potential healthcare businesses, which suggests they provide strategic guidance and access to their extensive network to help portfolio companies navigate the healthcare landscape effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.